1. Home
  2. CYTK vs DRS Comparison

CYTK vs DRS Comparison

Compare CYTK & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.78

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Leonardo DRS Inc.

DRS

Leonardo DRS Inc.

HOLD

Current Price

$40.78

Market Cap

8.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
DRS
Founded
1997
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.8B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
DRS
Price
$63.78
$40.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
6
Target Price
$84.81
$46.83
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
02-26-2026
02-24-2026
Dividend Yield
N/A
0.88%
EPS Growth
N/A
33.93
EPS
N/A
0.99
Revenue
$87,211,000.00
$3,569,000,000.00
Revenue This Year
$339.72
$11.94
Revenue Next Year
$79.08
$6.66
P/E Ratio
N/A
$41.43
Revenue Growth
2609.26
12.27
52 Week Low
$29.31
$28.17
52 Week High
$70.98
$49.31

Technical Indicators

Market Signals
Indicator
CYTK
DRS
Relative Strength Index (RSI) 51.02 65.30
Support Level $62.25 $40.10
Resistance Level $65.38 $41.99
Average True Range (ATR) 2.93 1.40
MACD 0.06 0.18
Stochastic Oscillator 64.02 70.42

Price Performance

Historical Comparison
CYTK
DRS

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

Share on Social Networks: